A recombinant plasmid was constructed with six synthetic DNA oligomers such that the DNA sequence corresponding to yeast tRNAPhe is flanked by a T7 promoter and a BstNI restriction site. Runoff transcription of the BstNI-digested plasmid with T7 RNA polymerase gives an unmodified tRNA of the expected sequence having correct 5' and 3' termini. This tRNAPhe transcript can be specifically aminoacylated by yeast phenylalanyl-tRNA synthetase and has a Km only 4-fold higher than that of the native yeast tRNAPle.
V,.. is very dependent on Mg2+ concentration. Comparison
of the melting profiles of the native and the unmodified tRNAPhe at different Mg2+ concentrations suggests that the unmodified tRNAPhe has a less stable tertiary structure. Using one additional DNA oligomer, a mutant plasmid was constructed having a guanosine to thymidine change at position 20 in the tRNA gene. A decrease in Vma./Km by a factor of 14 for aminoacylation of the mutant tRNAP`" transcript is observed.
A useful approach for understanding the relationship between structure and function of tRNA involves the physical and biochemical analysis of variant tRNA molecules. A number of methods have been used to create mutant tRNAs in which one or more nucleotides have been altered. Various mutagenesis techniques have produced a large number of mutant tRNA genes (1, 2) , but often the expression of the mutant gene is blocked at transcription or processing steps such that biochemical amounts of the tRNA cannot be isolated. tRNAs having specific nucleotide substitutions in the anticodon loop and the TTCG loop have been prepared by the removal of these nucleotides with RNase followed by the insertion of an altered oligoribonucleotide with RNA ligase (3, 4) . While this approach has produced many valuable data, specific substitution is limited to those regions of the molecule that are susceptible to partial nuclease digestion. Complete synthesis of two tRNAs has been achieved by joining synthetic oligoribonucleotides with RNA ligase (5, 6) . Although this would in principle allow for the synthesis of any desired tRNA sequence, the multiple ligations and subsequent purification of intermediates result in a low yield of final product.
It has been shown that the 3' terminus of brome mosaic virus RNA3, synthesized by in vitro runoff transcription of cloned DNA, can be specifically aminoacylated by tyrosyltRNA synthetase (7) . It therefore seemed clear that a tRNA lacking the modified nucleotides could be synthesized in a similar manner. In this paper, we describe a detailed method for the synthesis of an unmodified yeast tRNAPhC by runoff transcription using T7 RNA polymerase. The aminoacylation properties of the wild-type tRNAPhC transcript and a mutant transcript will be discussed. A preliminary account of some of this work has been reported earlier (8 was prepared from 32Pi (9) . T7 RNA polymerase was isolated from Escherichia coli BL21 harboring the plasmid pAR1219 and purified to a specific activity of 450,000 units/mg (10 (1988) minor products resulted from the incorporation of one or two additional non-template-directed nucleotides on the 3' terminus (15) and could be removed by preparative highresolution polyacrylamide gel electrophoresis. All subsequent experiments used this highly purified material (Fig. 3) .
To replace the 5'-terminal triphosphate present on the transcript with a 5' monophosphate, GMP was used to prime the transcription reaction. As shown in Fig. 4 , increasing concentrations of GMP in the transcription reaction mixture reduced the incorporation of [y-32P]GTP label at the 5' terminus of the full-length transcript without altering the amount of [a-32P]CTP incorporated. The presence of a 5'-terminal monophosphate for the GMP-primed reaction was confirmed by complete RNase T2 digestion of the [a-32P]CTP-labeled transcript followed by two-dimensional TLC analysis (Fig. 4 Inset) .
Aminoacylation of the tRNA"" Transcripts. The tRNAPh" transcripts having either a 5' monophosphate or triphosphate were compared to yeast tRNAPhe for phenylalanine acceptor activity using yeast phenylalanyl-tRNA synthetase. As shown in Fig. 5 , both tRNA transcripts could be aminoacylated by phenylalanyl-tRNA synthetase to >1300 pmol of phenylalanine/A260 unit of tRNA. This corresponds to >90o aminoacylation and demonstrates that the transcripts are essentially pure and competent for aminoacylation.
The kinetics of aminoacylation were determined for the three tRNAs in buffer A, which maximizes the activity of phenylalanyl-tRNA synthetase ( Table 1) . The Km and Vmax values obtained for the yeast tRNAPhe in this buffer are similar to those previously reported (3). Both tRNAPhC transcripts have a Km 4 times higher than tRNAPhe and a slightly lower Vmax, resulting in a 5 times lower Vmax/Km. This clearly demonstrates that the absence of the 14 modifications normally found in yeast tRNAPh' has only a modest effect on the aminoacylation kinetics under these conditions. Furthermore, the number of phosphates on the 5'-terminal guanosine has no effect on the reaction kinetics.
Loftfield et al. (16) have shown that the aminoacylation buffer conditions can greatly affect the rate of misacylation of noncognate tRNAs by yeast phenylalanyl-tRNA synthetase. Therefore, the aminoacylation kinetics of yeast tRNAPheand the tRNAPhe transcript having a 5'-terminal triphosphate were compared in buffer B, which maximizes the accuracy of phenylalanyl-tRNA synthetase. As shown in Table 1 , the respective Km values for tRNAPhe and the transcript are the same in both buffers, whereas the Vmax of Thermal Stability of the tRNA Transcript. The thermal melting profiles of yeast tRNAPhe and the tRNAPhe transcript were determined as a function of Mg2+ concentration. In the absence of Mg2+, both tRNAs show an initial broad transition at =60°C followed by a sharper transition at -70°C (Fig. 7) . As the concentration of Mg2I is increased, the transition for the transcript slowly becomes sharper and the melting temperature increases until -8 mM Mg2 +, at which point hydrolysis of the tRNA prevents further reliable data collection. In contrast, yeast tRNAPh, shows a single transition at 1.0 mM Mg2 + that is 6°C higher than the transcript.
This suggests that the transcript has a less-stable structure than the native yeast tRNAPh,. This is consistent with the finding that the absence of the ribosylthymine modification destabilizes E. coli tRNAfmet (18) .
Aminoacylation of a Mutant tRNAlhe Transcript. Because the aminoacylation kinetics are essentially the same for both should allow for a detailed evaluation of the phenylalanyltRNA synthetase recognition site. A mutant tRNA in which guanosine-20 was changed to uridine was prepared by runoff transcription of BstNI-digested p67YF4 (Fig. 3) . This particular mutation was chosen for several reasons. First, guanosine-20 does not participate in any secondary or tertiary interactions (19) . Therefore, any observed effect on aminoacylation as a result of this change would not be expected to be the consequence of an 'altered tertiary structure.
Second, tRNAPh`is the only known yeast tRNA with a guanosine at position 20, suggesting that it may be a discriminatory nucleotide (20) . Finally, kethoxalation of guanosine-20 reduces the extent of aminoacylation (21) . As shown in Fig. 5 , the mutant tRNA transcripts with either the 5' monophosphate or triphosphates could be fully aminoacylated. However, the kinetics of aminoacylation in buffers A and B revealed that both mutant tRNA transcripts exhibited a 5 times higher Km and a 2 times lower Vm.. than the wild-type tRNAPhe transcript (Table 1) . Therefore, the single nucleotide substitution at position + 20 has a large effect on aminoacylation, and the discrimination between the mutant and the wild-type tRNAPh`transcript remains the same in both buffers. DISCUSSION The method we have described for the in vitro synthesis of an unmodified tRNA by runoff transcription could be used for synthesizing virtually any tRNA, provided that the 5'-terminal sequence corresponds to an active T7 promoter. The fact that we observe efficient transcription with a mutant GCGGA promoter and the report of a number of other active promoters having changes in the +1 to +5 region (15) (24) . Thus, the interpretation of these results, which are based on heterologous systems, is unclear. The ability of the tRNAPhe transcript to aminoacylate normally in the presence of 15 mM Mg2+ also suggests that the absence of the modified nucleotides do not greatly alter the tertiary folding of the tRNA. This conclusion is consistent with the crystal structure of yeast tRNAPhC, which reveals that none of the modifications is directly involved in any secondary or tertiary hydrogen-bonding interactions (25) . All available experimental data on the structure of unmodified tRNAs also indicate that the molecule is folded normally. Analysis of the tertiary structure of the partially modified yeast tRNAPbC precursor using chemical and enzymatic probes revealed a structure very similar to the mature tRNAPhe (26) . The rate of Pb2'-induced cleavage at nucleotide 17 for the unmodified tRNA transcript is only 2 times slower than that of the native tRNAPhe (27) . Finally, the NMR spectrum of the tRNA transcript in H20 indicates that most of the tertiary interactions that can be detected by NMR are present (K. Hall, personal communication).
Unlike the results obtained at 15 mM Mg2+, below 5 mM Mg2 + the rate of aminoacylation for the unmodified tRNAPh, transcript is much slower than that of the native yeast tRNAPh,. This correlates with the fact that at lower Mg2+ concentrations the unmodified tRNA transcript shows a much broader melting profile and suggests that the unmodified tRNA transcript may not have the same structure as the native tRNAPhe under these conditions. It is interesting to note that the tight-binding Mg2 + ion in the anticodon loop of the native yeast tRNAPh, is coordinated through water to both Y37 and T39 (28) . In addition, the Mg2+ ion, which serves to stabilize the sharp bend in the polynucleotide chain at nucleotide 10, is also in close proximity to m2G-10 normally found in native yeast tRNAPhe. Therefore, the absence of these modifications could result in altered binding of the Mg2+ ions.
The ease of synthesizing mutant tRNAs by this method allows for a number of structure-function experiments. Two such experiments were carried out in this work. In the first, it was shown that introducing a 5'-terminal triphosphate on the tRNA had no effect on the kinetics of aminoacylation. Sprinzl and Graeser (29) showed that the aminoacylation of yeast tRNAPhb by phenylalanyl-tRNA synthetase is not affected by removal of the 5' phosphate. The fact that the 5' phosphate lies along the top of the aminoacyl stem in the L-shaped structure suggests that this part of the tRNA is either not in contact with the synthetase or the space and charge occupied by the two additional phosphates can be accommodated by the enzyme. Second, it was shown that the overall rate of aminoacylation for the tRNA transcript with the guanosine to uridine change at position 20 is 14 times lower than that of the wild-type transcript. Based on the crystal structure, we do not expect this mutant tRNA to have a different tertiary structure. We have shown elsewhere (27) that the Pb2+-induced cleavage properties of the undine-20 transcript are the same as that of the wild-type transcript. Preliminary NMR analysis of the mutant tRNA also indicates that it is not structurally different from the wild-type transcript (K. Hall, personal communication). It is tempting to conclude that guanosine-20 interacts directly with yeast phenylalanyl-tRNA synthetase. However, it is important to note that in yeast tRNAPhC, the N7 and O6 of guanosine-20 are coordinated (presumably through water) to one of the tightly bound Mg2+ ions (30) . It is therefore also possible that the loss of these functional groups in the mutant tRNA results in a lower affinity for a Mg2 + ion, which also interacts directly with the synthetase.
